ABSTRACT
INTRODUCTION Obesity is a known risk factor for the development of insulin resistance and other cardiometabolic disorders. Recently, the gut microbiome has been associated with obesity and subsequent health complications. Exercise has been regularly utilized as a therapeutic intervention to treat obesity and its associated comorbidities. This study examined the effects of a 6-week resistance training exercise program (RT) on the diversity, composition, and metabolic pathways of the gut microbiome.
METHODS Sedentary young adults (age 18-35 years) with overweight and obesity (BMI 25-45 kg/m2) were recruited to participate in this randomized controlled trial. Participants were randomized to RT (n=16), a 6-week resistance training program (3 days/week), or control (CT) (n=16), a non-exercising control. Main outcomes of the study included gut microbiome measures (taxa abundances, diversity, and predicted function) and cardiometabolic outcomes (blood pressure (BP) and glucoregulation).
RESULTS Increased abundances of Roseburia, a short chain fatty acid (SCFA) producer and predicted starch and sucrose metabolism pathway were observed over 6 weeks (W6) with RT in comparison to CT (group × week, p<0.05, q<0.25). RT also induced higher abundance of microbial flagellar assembly, a pathway involved in cell motility, at W6 compared to CT (group × week, p<0.05, q<0.25). Moreover, RT resulted in higher QUICKI and lower diastolic BP at W6 compared to CT (BL-adjusted p<0.05).
CONCLUSION This study provides preliminary evidence that resistance training increases abundance of selected SCFA producers and microbial pathways and improves cardiometabolic health. Additionally, the associations of cardiometabolic indicators with the microbial community structure warrants further investigation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04906525
Funding Statement
This study did not receive any funding. It was funded by internal university funds.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of University of Missouri-Columbia gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Revisions made to include additional analyses.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
